G1 Therapeutics, Inc.
USD7.16
+0.01 (+0.14%)
CEO
John E. Bailey Jr.
IPO Date
2017-05-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.15
Prev. Close
$7.15
Day Low
$7.14
Day High
$7.16
52W Low
$1.08
52W High
$7.19
Market Cap
$0.38B
Volume
1.10M
| -1.6 |
| 31 Dec 2021 | FY | 93.6% | -471.3% | 25.4% | -58.4% | -0.14 | 8.82 | -2.9 |
| 31 Dec 2020 | FY | 100.0% | -219.2% | 22.8% | -43.4% | -0.06 | 9.23 | -6.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 36.2% | -42.9% | -0.03 | 13.71 | -8.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 39.8% | -23.0% | 0.00 | 29.94 | -7.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -64.4% | -57.2% | 0.00 | 8.94 | -9.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -71.1% | -62.8% | 0.00 | 8.52 | -10.1 |
| 31 Dec 2015 | FY | -2338.7% | -3881.8% | -93.3% | -84.8% | 0.00 | 10.96 | -15.1 |
| 31 Dec 2014 | FY | -381.4% | -688.6% | -206.7% | -187.9% | 0.00 | 10.70 | -42.7 |
| -5.8 |
| 31 Dec 2023 | Q4 | 91.6% | -73.1% | -30.7% | -9.0% | 1.62 | 3.87 | -3.6 |
| 30 Sept 2023 | Q3 | 75.0% | -148.0% | 2.4% | -13.7% | -0.01 | 3.75 | -1.0 |
| 30 Jun 2023 | Q2 | 96.7% | 20.5% | 15.1% | 5.9% | 0.97 | 4.14 | 3.7 |
| 31 Mar 2023 | Q1 | 88.7% | -251.3% | 4.3% | -20.1% | -0.01 | 4.57 | -1.1 |
| 31 Dec 2022 | Q4 | 90.3% | -328.3% | -48.9% | -17.9% | 1.22 | 5.04 | -1.9 |
| 30 Sept 2022 | Q3 | 95.3% | -107.2% | -55.0% | -15.2% | 1.79 | 4.24 | -5.3 |
| 30 Jun 2022 | Q2 | 90.8% | -396.6% | -63.2% | -22.4% | 1.24 | 4.75 | -1.3 |
| 31 Mar 2022 | Q1 | 90.3% | -747.7% | -51.5% | -23.6% | 0.82 | 5.96 | -1.6 |